Client spotlight

Island Pharmaceuticals

Island (ASX: ILA) is focused on areas of unmet need for drugs that can address urgent viral diseases, public health or biosecurity threats. The Company is executing a dual development strategy for its assets, ISLA-101 and Galidesivir. ISLA-101 has a well-established safety profile, being repurposed for the prevention and treatment of dengue fever and other mosquito (or vector) borne diseases. Galidesivir is a clinical-stage antiviral molecule with a broad spectrum of activity in over 20 RNA viruses, including high-priority threats such as Ebola, Marburg, MERS, Zika and Yellow fever – viruses with significant unmet medical needs and that may contribute to national security threats.

Visit www.islandpharmaceuticals.com for more on Island Pharmaceuticals.

Maclean health

Maclean Health is a Sacramento, California-based medical and pharmaceutical products wholesale distributor with a specialization in supplying market innovators to government and private healthcare partners. The company has established contracting vehicles across key government channels — including GSA Schedule, the Medical-Surgical Prime Vendor (MSPV) Blanket Purchase Agreement, and Distribution and Pricing Agreement (DAPA) — positioning it as a trusted channel partner for manufacturers seeking access to the government sector. Led by President and CEO John Deterding and Chief Medical Officer Rear Admiral Louis Tripoli, M.D. (Ret.), Maclean Health streamlines the procurement and contracting process for their clients, identifying opportunities to optimize sales improving access to products and services for the warfighter. For more information, visit, www.macleanhealth.com.

Vasomune therapeutics, Inc.

Vasomune Therapeutics is a private biotechnology company developing Pegevongitide (AV-001), a first-in-class fully synthetic PEGylated peptide targeting the Tie2 receptor. Activation of the Tie2 receptor by Pegevongitide plays a critical role in improving vascular stability, barrier integrity and endothelial quiescence. For more infomation, please visit https://vasomune.com.